David Brierly

Senior Director, Head of UK Quantitative Biosciences at Merck (MSD)

With a career spanning 20 years in both academic and pharmaceutical environments, Brierly works at the interface between assay development, screening and automation technologies. He has actively supported the SLAS organization and community for over a decade, contributing through journal publications, multiple conference track chair roles, and more recently as a member of the Scientific Research Advisory Committee.